Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic.

ABSTRACT:

Aims

Our objective was to determine the ventricular arrhythmia burden in implantable cardioverter-defibrillator (ICD) patients during COVID-19.

Methods and results

In this multicentre, observational, cohort study over a 100-day period during the COVID-19 pandemic in the USA, we assessed ventricular arrhythmias in ICD patients from 20 centres in 13 states, via remote monitoring. Comparison was via a 100-day control period (late 2019) and seasonal control period (early 2019). The primary outcome was the impact of COVID-19 on ventricular arrhythmia burden. The secondary outcome was correlation with COVID-19 incidence. During the COVID-19 period, 5963 ICD patients underwent remote monitoring, with 16 942 episodes of treated ventricular arrhythmias (2.8 events per 100 patient-day

SUBMITTER: O'Shea CJ 

PROVIDER: S-EPMC7953962 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature